PR Greipp

3.0k total citations
33 papers, 2.3k citations indexed

About

PR Greipp is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, PR Greipp has authored 33 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 16 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in PR Greipp's work include Multiple Myeloma Research and Treatments (20 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers) and Cancer Treatment and Pharmacology (7 papers). PR Greipp is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers) and Cancer Treatment and Pharmacology (7 papers). PR Greipp collaborates with scholars based in United States and Israel. PR Greipp's co-authors include RA Kyle, W. Michael O’Fallon, RA Kyle, JA Katzmann, MA Gertz, GW Dewald, TE Witzig, JA Lust, Rafaël Fonseca and S. Vincent Rajkumar and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

PR Greipp

33 papers receiving 2.2k citations

Peers

Countries citing papers authored by PR Greipp

Since Specialization

Citations

This map shows the geographic impact of PR Greipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PR Greipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PR Greipp more than expected).

Fields of papers citing papers by PR Greipp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PR Greipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PR Greipp. The network helps show where PR Greipp may publish in the future.

Co-authorship network of co-authors of PR Greipp

This figure shows the co-authorship network connecting the top 25 collaborators of PR Greipp. A scholar is included among the top collaborators of PR Greipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PR Greipp. PR Greipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis 2008 ·Haematologica ·MA Gertz, (unknown), John A. Lust, PR Greipp, T.E. Witzig, Robert A. Kyle	11
2	Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma 1999 ·Leukemia ·S. Vincent Rajkumar, Rafaël Fonseca, TE Witzig, MA Gertz, PR Greipp	134
3	Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma [see comments] 1996 ·Blood ·T.E. Witzig, MA Gertz, JA Lust, RA Kyle, O'Fallon Wm, PR Greipp	86
4	Pathogenetic relation between monoclonal gammopathies of undetermined significance and multiple myeloma. 1995 ·PubMed ·PR Greipp, (unknown)	16
5	Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments] 1993 ·Blood ·PR Greipp, JA Lust, O'Fallon Wm, JA Katzmann, TE Witzig, RA Kyle	5
6	Advances in the diagnosis and management of myeloma. 1992 ·PubMed ·PR Greipp	51
7	Response rates and survival in primary systemic amyloidosis 1991 ·Blood ·MA Gertz, RA Kyle, PR Greipp	132
8	Models of S-phase determination in lymphomas from flow cytometric DNA content histograms: comparison with the bromodeoxyuridine labeling index. 1991 ·PubMed ·Pascale B. Beauregard, (unknown), (unknown), PR Greipp, (unknown), (unknown), (unknown), Wieand Hs	10
9	Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma 1988 ·Blood ·PR Greipp, JA Katzmann, W. Michael O’Fallon, RA Kyle	123
10	Resolution of Acquired Factor X Deficiency and Amyloidosis with Melphalan and Prednisone Therapy 1987 ·New England Journal of Medicine ·John Camoriano, PR Greipp, (unknown), E. J. Walter Bowie	25
11	Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases 1986 ·Blood ·RA Kyle, PR Greipp, W. Michael O’Fallon	23
12	Gamma heavy-chain disease involving upper airway. 1985 ·PubMed ·(unknown), (unknown), PR Greipp, (unknown)	3
13	The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis 1985 ·Blood ·GW Dewald, RA Kyle, (unknown), PR Greipp	21
14	Multiple myeloma: significance of plasmablastic subtype in morphological classification 1985 ·Blood ·PR Greipp, (unknown), RA Kyle, W. Michael O’Fallon	189
15	Multiple myeloma: circulating lymphocytes that express plasma cell antigens 1984 ·Blood ·(unknown), JA Katzmann, PR Greipp, (unknown), (unknown), RA Kyle	7
16	Localization of eosinophil granule major basic protein in human basophils. 1983 ·The Journal of Experimental Medicine ·S.J. Ackerman, G M Kephart, Thomas M. Habermann, PR Greipp, Gerald J. Gleich	83
17	Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma 1983 ·Blood ·PR Greipp, RA Kyle	5
18	Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo 1978 ·Blood ·RA Kyle, PR Greipp	106
19	Platelet to leukocyte adherence phenomena associated with thrombocytopenia 1976 ·Blood ·PR Greipp, HR Gralnick	24
20	Platelet to leukocyte adherence phenomena associated with thrombocytopenia 1976 ·Blood ·PR Greipp, HR Gralnick	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact